07Apr 2023
Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia

Amygdala signal abnormality and cognitive impairment in drug-naïve schizophrenia

The study investigated the relationship between amygdala resting state magnetic resonance imaging (rsMRI) signal and cognitive function in drug-naïve patients with schizophrenia (SC) compared to healthy controls (HCs). The findings revealed that SC patients had increased severity of symptoms measured by the Positive and Negative Syndrome Scale (PANSS) and decreased cognitive function measured by the Repeatable Battery for the Assessment of Neuropsychological Status (RBANS). The study also found correlations between the structural and functional indicators of the amygdala with PANSS and RBANS scores, suggesting that abnormal volume and function of the amygdala may play important roles in the disease process of SC and are closely related to cognitive impairment.

  • #psychiatry

Like

Save

Share